Loading...
Dernières publications
-
Anaís Mariscal, Carmen Martínez, Lea Goethals, Elena Cortés-Vicente, Elisabeth Moltó, et al.. Modified radioimmunoassay versus ELISA to quantify anti-acetylcholine receptor antibodies in a mouse model of myasthenia gravis. Journal of Immunological Methods, 2024, 534, pp.113748. ⟨10.1016/j.jim.2024.113748⟩. ⟨hal-04774927⟩
-
Lidia Almenara-Fuentes, Silvia Rodriguez-Fernandez, Estela Rosell-Mases, Katerina Kachler, Axel You, et al.. A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens. Nanomedicine: Nanotechnology, Biology and Medicine, 2023, pp.102635. ⟨10.1016/j.nano.2022.102635⟩. ⟨hal-03885962⟩
Chiffres clés
59
Publications avec texte intégral
Open Access
47 %
Mots clés
Genetic associations
PBMC
Experimental autoimmune myasthenia gravis EAMG
COVID-19
Neuromuscular junction
Th17 cells
LMNA
Exercise
Myasthenia Gravis
Interleukine-23
Puberty
COX2
Interferon-β
Quality of life
Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype
B cells
Lamin A/C nuclei
Gender
Autoimmune disease
Genetics
Autoimmunity
Interferon
Cell-cell communication
Myasthenia Gravis MG
Thymectomy
MG patients
Il-23
Autoimmune diseases
Acetylcholine receptor antibodies
Early-onset myasthenia gravis
Interferon type-I
Antimir-150
Interferonopathy
Ferrites
Immune regulation
CCL21
Acetylcholine receptor
Heart failure
Anticorps monoclonal
Immune response
Human myoblasts
Germinal center
CD31
Acides nucléiques endogènes
Chemokines
Transcriptome
CTCF
Experimental autoimmune myasthenia gravis
Chronicity
Fragile X syndromes
Endogenous nucleic acids
Myasthenia gravis
Follicular hyperplasia
Cardiomyopathy
Interferon de type I
Centres germinatifs ectopiques
Complete Freund's adjuvant
Auto-immunité
Glucocorticoids
Immunology and Microbiology Section
Etiology
Cytokines
Interferon IFN
Myoblasts
Immunotherapy
Innate immunity
Germinal centers
Gd T cells
Interleukin 23
DICER
Immunity
Thymus
Inflammation
Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration
Interféron de type I
CXCL13-CXCR5
Adaptive immunity
Thymoma
Chronic inflammation
Animal models
Thymic epithelial cells
Cellules th17
BAFF
Acetylcholine receptors
Experimental mouse models
Conduction disease
FMR1
AChR antibodies
Age
Assay comparison
Long-term follow-up
Interferon type I
Myasthénie grave
Ectopic germinal centers
Disease susceptibility
M3243AG
Experimental models
Chemokine
Clinical cell transplantation
Inflammatory cytokines